Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02263963 · ClinicalTrials.gov registry record · Phase 4
The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.
A Phase 4 study, sponsored by Corewell Health West.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02263963 is a Phase 4 study that has completed, run by Corewell Health West. The registered enrollment target is 50 participants.
The verdict
NCT02263963, a Phase 4 study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
Interventions
- DRUG Exparel
- PROCEDURE TAP Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02263963
The ClinicalTrials.gov registry entry for NCT02263963 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT02263963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02263963 about?
NCT02263963 is a clinical study titled "The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.". The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
What is the current status of trial NCT02263963?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2013-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02263963?
The interventions under investigation include: Exparel (DRUG), TAP Block (PROCEDURE).
Who is sponsoring clinical trial NCT02263963?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.